• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重组蓖麻毒素A链氨基末端的定点诱变

Site-directed mutagenesis at amino terminus of recombinant ricin A chain.

作者信息

Bradley J L, Piatak M, Lane J A, McGuire P M

机构信息

Department of Biochemistry and Molecular Biology, University of Florida, Gainesville.

出版信息

Int J Pept Protein Res. 1989 Jul;34(1):2-5. doi: 10.1111/j.1399-3011.1989.tb00999.x.

DOI:10.1111/j.1399-3011.1989.tb00999.x
PMID:2551831
Abstract

Successful immunotoxin therapy may depend upon reduction of the size of the components in order to decrease antigenicity and rate of clearance. In initial attempts to modify the A chain of ricin by deletion analyses within a prokaryotic expression system, coding sequences were modified by the insertion of unique restriction endonuclease sites and by the removal of 22 codons near the 5' terminus. The work presented here examines the expression, solubility, and activity of these mutant proteins and demonstrates that while amino acid residues may be altered in this region, the deletion of residues 19 through 40 yields an insoluble and inactive toxin molecule.

摘要

成功的免疫毒素疗法可能取决于减小其组分的大小,以降低抗原性和清除率。在最初尝试通过原核表达系统中的缺失分析来修饰蓖麻毒素A链时,编码序列通过插入独特的限制性内切酶位点以及去除5'末端附近的22个密码子进行了修饰。本文展示的研究考察了这些突变蛋白的表达、溶解性和活性,并证明虽然该区域的氨基酸残基可能会发生改变,但删除19至40位残基会产生不溶性且无活性的毒素分子。

相似文献

1
Site-directed mutagenesis at amino terminus of recombinant ricin A chain.重组蓖麻毒素A链氨基末端的定点诱变
Int J Pept Protein Res. 1989 Jul;34(1):2-5. doi: 10.1111/j.1399-3011.1989.tb00999.x.
2
High-level expression and simplified purification of recombinant ricin A chain.
Protein Expr Purif. 1992 Oct;3(5):386-94. doi: 10.1016/s1046-5928(05)80040-3.
3
Site-directed mutagenesis of ricin A chain Trp 211 to Phe.
Int J Pept Protein Res. 1990 Apr;35(4):365-6. doi: 10.1111/j.1399-3011.1990.tb00062.x.
4
Elongation and folding of nascent ricin chains as peptidyl-tRNA on ribosomes: the effect of amino acid deletions on these processes.蓖麻毒素新生链在核糖体上作为肽基 - tRNA的延伸与折叠:氨基酸缺失对这些过程的影响。
J Mol Biol. 1995 Sep 15;252(2):203-12. doi: 10.1006/jmbi.1995.0488.
5
The expression of functional ricin B-chain in Saccharomyces cerevisiae.
Biochim Biophys Acta. 1988 Sep 7;950(3):385-94. doi: 10.1016/0167-4781(88)90135-2.
6
Preparation and characterization of recombinant proricin containing an alternative protease-sensitive linker sequence.含有替代蛋白酶敏感连接序列的重组原蓖麻毒素的制备与表征
Bioconjug Chem. 1992 Sep-Oct;3(5):375-81. doi: 10.1021/bc00017a004.
7
Double-lectin site ricin B chain mutants expressed in insect cells have residual galactose binding: evidence for more than two lectin sites on the ricin toxin B chain.在昆虫细胞中表达的双凝集素位点蓖麻毒素B链突变体具有残余半乳糖结合能力:证明蓖麻毒素B链上存在两个以上的凝集素位点。
Bioconjug Chem. 1996 Nov-Dec;7(6):651-8. doi: 10.1021/bc960056b.
8
Recombinant ricin B chain fragments containing a single galactose binding site retain lectin activity.
Arch Biochem Biophys. 1992 Apr;294(1):291-6. doi: 10.1016/0003-9861(92)90171-r.
9
The effects of N-glycosylation on the lectin activity of recombinant ricin B chain.
Carbohydr Res. 1991 Jun 25;213:19-25. doi: 10.1016/s0008-6215(00)90594-9.
10
Major structural differences between pokeweed antiviral protein and ricin A-chain do not account for their differing ribosome specificity.商陆抗病毒蛋白和蓖麻毒蛋白A链之间的主要结构差异并不能解释它们不同的核糖体特异性。
Eur J Biochem. 1996 Jan 15;235(1-2):159-66. doi: 10.1111/j.1432-1033.1996.00159.x.

引用本文的文献

1
Protein engineering and site-directed mutagenesis. Patents and literature.
Appl Biochem Biotechnol. 1990 Oct;26(1):107-13. doi: 10.1007/BF02798396.
2
Role of arginine 180 and glutamic acid 177 of ricin toxin A chain in enzymatic inactivation of ribosomes.蓖麻毒素A链中精氨酸180和谷氨酸177在核糖体酶促失活中的作用。
Mol Cell Biol. 1990 Dec;10(12):6257-63. doi: 10.1128/mcb.10.12.6257-6263.1990.